Received: 13 September 2019
Accepted: 4 November 2019
First Online: 17 December 2019
Ethics approval and consent to participate
: <i>In vivo</i> efficacy of the developed formulation was on Sprague–Dawley rats. Study was started after getting the approval from Institutional Animal Ethical committee (Approval No: PERD/IAEC/2010/001).
: Not applicable
: The authors declare that they have no competing interests.